Jose Rafael Blesa

Jose Rafael Blesa

Auto-generated profile, based on publicly available information

Jose Rafael Blesa

Fundación Valenciana de Investigaciones Biomédicas, Instituto de Investigaciones Citológicas, Amadeo de Saboya, 4, 46010 Valencia, Spain

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2009 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
FGFei Gao
Fei Gao
Pablo Botella AsuncionPablo Botella Asuncion
Pablo Botella Asuncion
ACAvelino Corma
Avelino Corma
JBJose Blesa
Jose Blesa
LDLin Dong
Lin Dong

14 August 2014 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
SSS Saez-Atienzar
S Saez-Atienzar
LBL Bonet-Ponce
L Bonet-Ponce
JBJ R Blesa
J R Blesa
FRFrancisco J. Romero
Francisco J. Romero
MMM P Murphy
M P Murphy
MGMaria F Galindo
Maria F Galindo
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been associated with Parkinson’s disease, and its inhibition opens potential new therapeutic options. Among the drug inhibitors of both wild-type and mutant LRRK2 forms is the 2-arylmethyloxy-5-subtitutent-N-arylbenzamide GSK257815A. Using the well-established dopaminergic cell culture model SH-SY5Y, we have investigated the effects of GSK2578215A on crucial neurodegenerative features such as mitochondrial dynamics and autophagy. GSK2578215A induces mitochondrial fragmentation of an early step preceding autophagy. This increase in autophagosome results from inhibition of fusion rather than increases in synthesis. The observed effects were shared with LRRK2-IN-1, a well-described, structurally distinct kinase inhibitor compound or when knocking down LRRK2 expression using siRNA. Studies using the drug mitochondrial division inhibitor 1 indicated that translocation of the dynamin-related protein-1 has a relevant role in this process. In addition, autophagic inhibitors revealed the participation of autophagy as a cytoprotective response by removing damaged mitochondria. GSK2578215A induced oxidative stress as evidenced by the accumulation of 4-hydroxy-2-nonenal in SH-SY5Y cells. The mitochondrial-targeted reactive oxygen species scavenger MitoQ positioned these species as second messengers between mitochondrial morphologic alterations and autophagy. Altogether, our results demonstrated the relevance of LRRK2 in mitochondrial-activated pathways mediating in autophagy and cell fate, crucial features in neurodegenerative diseases.

30 December 2014 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Closed access
PDF file
RAR. Alis
R. Alis
FSF. Sanchis‐Gomar
F. Sanchis‐Gomar
CPC. Primo‐Carrau
C. Primo‐Carrau
SLS. Lozano‐Calve
S. Lozano‐Calve
MDM. Dipalo
M. Dipalo
GLG. Lippi
G. Lippi

1 April 2007 in Gene
Verified
Journal Article
Closed access
JBJosé R. Blesa
José R. Blesa
JPJesús A. Prieto-Ruiz
Jesús A. Prieto-Ruiz
JHJosé M. Hernández-Andreu
José M. Hernández-Andreu
JHJosé Hernández-Yago
José Hernández-Yago

1 February 2008 in Biochemistry and Cell Biology
Verified
Journal Article
Closed access
JBJosé R. Blesa
José R. Blesa
JPJesús A. Prieto-Ruiz
Jesús A. Prieto-Ruiz
BABeth A. Abraham
Beth A. Abraham
BHBridget L. Harrison
Bridget L. Harrison
AHAnita A. Hegde
Anita A. Hegde
JHJosé Hernández-Yago
José Hernández-Yago
The human TOMM34 gene encodes a cytosolic protein with chaperone-like activity that helps import some preproteins to the mitochondria by keeping them in an unfolded, import-compatible state. TOMM34 was found to be upregulated frequently in colorectal tumors, suggesting that it also has a role in the growth of cancer cells. In this context, TOMM34 is a potential target for novel anticancer drugs, and it might also be used in the diagnosis of colorectal cancer. Nuclear respiratory factors (NRFs) play an important role in governing the nuclear–mitochondrial interactions implicated in mitochondrial biogenesis. Our previous studies revealed that NRFs promote the expression of the major members of the mitochondrial transport machinery, TOMM70 and TOMM20. Here we report the existence of binding sites for NRF-1, Sp1, and NRF-2 in the 5′ region of the human TOMM34 gene. We determined the effects of mutations at these sites on promoter activity in HeLa S3 and A204 cells, in conjunction with chromatin immunoprecipitation experiments, electrophoretic mobility shift assays, and in vivo methylation analysis of the promoter region. We conclude that NRF-1 is the main transcription factor regulating the expression of TOMM34. Sp1 interacts with NRF-1 to stimulate the promoter's full activity.

2 June 1999 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
JBJavier Boix-Ferrero
Javier Boix-Ferrero
APAntonio Pellín
Antonio Pellín
RBRafael Blesa
Rafael Blesa
MAManuel Adrados
Manuel Adrados
ALA. Llombart-Bosch
A. Llombart-Bosch